Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 6, 2012

View Archived Issues

Roche reflects on accomplishments of second quarter 2012

Sirolimus reduces skin cancer occurrence in renal transplant recipients

Pol I inhibitor shows anticancer potency in vitro and in vivo

MEK inhibitor improves survival in METRIC trial

Kyowa Hakko Kirin presents overview of first half 2012

Researchers at Novartis disclose novel beta-secretase inhibitors

Sanofi updates R&D progress of second quarter 2012

New sodium channel blockers designed by Pfizer

Korean group prepares new GPR119 receptor ligands

Bionor Pharma presents new candidate vaccines

Belgian scientists divulge novel antiviral alphabodies

Beta Pharma patents novel protein kinase inhibitors

GSK confirms submissions for dabrafenib and trametinib

New technique offers alternative to gene therapy

Zaltrap approved in U.S. for cancer indication

ACT advances stem cell trial for dry AMD

FDA assigns PDUFA action date for enzalutamide NDA

Ono kicks off first-in-human study of peptide-cocktail vaccine

Pluristem reports second successful compassionate use of PLX cells

Daiichi Sankyo presents overview of first quarter fiscal 2012

UCB reviews events of first half 2012

U.S. university and Novartis form global alliance for anticancer T-cell immunotherapies

NIH awards grant to support study of Immuron candidate drug for steatohepatitis

Marina Biotech grants Novartis license for CRN technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...